Johnson & Johnson reported Q4 2025 revenue of $24.6 billion, beating expectations, while EPS came in at $2.46, just below ...

Travelers posted a strong Q4 2025, reporting EPS of $11.13 on $12.43 billion in revenue, as the insurer benefited from solid ...

Netflix fell in premarket despite beating Q4 estimates, as weaker growth trends and the Warner Bros. Discovery deal overhang ...

Truist delivered Q4 EPS of $1.00 with $5.25 billion in revenue, while the bank highlighted strategic initiatives aimed at ...

Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, ...

Intel stock rose in premarket trading as investors looked ahead to Q4 earnings, betting CEO Lip-Bu Tan’s turnaround plan is ...

Despite surpassing its average analyst price target, Micron’s forward valuation and memory bottleneck economics point toward ...

ImmunityBio shares jumped in premarket trading after the FDA outlined next steps for expanding ANKTIVA’s bladder cancer label ...

Fastenal posted Q4 EPS of $0.26, matching estimates, while revenue came in at $2.03B, slightly below forecasts. The company ...

With risk assets retreating and commodities exploding higher, investors are hunting for durable growth stories trading below ...

M posted a Q4 earnings and revenue beat, delivering $1.83 adjusted EPS and $6.1 billion in sales, while forecasting growth in ...

RAPT Therapeutics stock surged over 63% after GSK agreed to buy the company for $58 per share in a $2.2 billion deal.